Study Detail

Non-inferiority study comparing immunogenicity against COVID-19 of VLA2001 with [ACTIVE COMPARATOR]

A randomized, double-blinded, phase 2/3 Study to assess Safety and Immunogenicity of VLA2001 Vaccine, compared to placebo, for the prevention of covid-19, performed in two groups of healthy Adults, Cohort A aged 18 -64 years and Cohort B 65 years and olde

Status: Closed

Type: Interventional

Funder: not available

Sponsor: Valneva

CI: not available

IRAS-Number: 294164

CPMS-ID: 48118

Approval Date: 13 January 2021

Study URL:

https://valneva.com/research-development/covid-19-vla2001/

Back to listing